X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1188) 1188
Book Chapter (8) 8
Magazine Article (3) 3
Book / eBook (2) 2
Conference Proceeding (1) 1
Reference (1) 1
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (897) 897
life sciences & biomedicine (861) 861
male (787) 787
animals (692) 692
humans (632) 632
neuralgia - chemically induced (490) 490
neurosciences & neurology (481) 481
neuralgia - drug therapy (436) 436
neurosciences (410) 410
rats (388) 388
female (384) 384
pain (312) 312
rats, sprague-dawley (300) 300
neuropathic pain (269) 269
disease models, animal (265) 265
clinical neurology (243) 243
middle aged (219) 219
mice (211) 211
neuralgia - physiopathology (208) 208
neuralgia - metabolism (195) 195
care and treatment (191) 191
aged (183) 183
adult (176) 176
hyperalgesia - chemically induced (176) 176
anesthesiology (174) 174
pharmacology & pharmacy (161) 161
neuropathy (155) 155
chemotherapy (147) 147
hyperalgesia - drug therapy (137) 137
analgesics - therapeutic use (136) 136
neuralgia - etiology (135) 135
pain measurement (135) 135
cancer (130) 130
analysis (114) 114
neuralgia - pathology (108) 108
hyperalgesia - physiopathology (105) 105
analgesics - pharmacology (103) 103
antineoplastic agents - adverse effects (103) 103
dose-response relationship, drug (103) 103
trigeminal neuralgia - drug therapy (102) 102
abridged index medicus (98) 98
pain threshold - drug effects (98) 98
neurology (97) 97
mice, inbred c57bl (94) 94
treatment outcome (93) 93
rodents (91) 91
pain perception (89) 89
analgesics (85) 85
peripheral nervous system diseases - chemically induced (85) 85
rats, wistar (85) 85
research (85) 85
time factors (81) 81
hyperalgesia - metabolism (80) 80
spinal cord - metabolism (80) 80
spinal cord (78) 78
carbamazepine - adverse effects (73) 73
neuralgia (72) 72
ganglia, spinal - metabolism (69) 69
inflammation (69) 69
neuralgia - prevention & control (68) 68
nervous system (67) 67
paclitaxel (67) 67
spinal cord - drug effects (67) 67
inflammation - chemically induced (65) 65
hyperalgesia (64) 64
behavior, animal - drug effects (63) 63
ganglia, spinal - drug effects (63) 63
research article (63) 63
peripheral neuropathy (62) 62
chronic pain (60) 60
health aspects (60) 60
oxaliplatin (57) 57
pain management (57) 57
neuralgia - complications (56) 56
allodynia (55) 55
analgesics - adverse effects (53) 53
hyperalgesia - etiology (53) 53
neurons (52) 52
paclitaxel - adverse effects (52) 52
pain measurement - methods (52) 52
medicine & public health (51) 51
pain measurement - drug effects (50) 50
trigeminal neuralgia - chemically induced (50) 50
biochemistry & molecular biology (49) 49
carbamazepine - therapeutic use (49) 49
general & internal medicine (49) 49
medicine (49) 49
medicine, general & internal (49) 49
oncology (48) 48
aged, 80 and over (47) 47
neuralgia - therapy (47) 47
physical stimulation (47) 47
drug therapy (45) 45
pregabalin (45) 45
peripheral nervous system diseases - drug therapy (44) 44
antineoplastic agents (42) 42
gabapentin (42) 42
pain - chemically induced (42) 42
pain threshold - physiology (42) 42
risk factors (42) 42
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1144) 1144
German (24) 24
Japanese (21) 21
French (14) 14
Spanish (10) 10
Russian (6) 6
Italian (5) 5
Polish (3) 3
Portuguese (3) 3
Dutch (2) 2
Chinese (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2013, ISBN 9781439862186, xii, 221
..., this reference provides insight into chemotherapy-induced neuropathic pain cancer survivors suffer... 
Side effects | chemically induced | therapy | adverse effects | Neuralgia | Pain Measurement | Antineoplastic agents | Chronic Pain
Book
PloS one, ISSN 1932-6203, 01/2017, Volume 12, Issue 1, pp. e0170814 - e0170814
Chemotherapy-induced peripheral neuropathy (CIPN) and associated neuropathic pain is a debilitating adverse effect of cancer treatment... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Hyperalgesia - chemically induced | Neuralgia - genetics | Spleen - immunology | Chemokine CCL2 - immunology | Male | Spleen - drug effects | Activating Transcription Factor 3 - immunology | T-Lymphocytes, Regulatory - pathology | Hyperalgesia - pathology | T-Lymphocytes, Regulatory - immunology | Neurofilament Proteins - genetics | Neuralgia - immunology | Chemokine CCL3 - genetics | Microglia - pathology | Lymph Nodes - drug effects | Activating Transcription Factor 3 - genetics | Receptors, Purinergic P2Y12 - genetics | Gene Expression | Receptors, Purinergic P2Y12 - immunology | Mice, Transgenic | Lymph Nodes - immunology | Spinal Cord - immunology | Hyperalgesia - immunology | T-Lymphocytes, Regulatory - drug effects | Hyperalgesia - genetics | Ganglia, Spinal - pathology | Mice | CD8-Positive T-Lymphocytes - immunology | Ganglia, Spinal - drug effects | CD8-Positive T-Lymphocytes - pathology | Lymph Nodes - pathology | Spinal Cord - drug effects | Chemokine CCL3 - immunology | Sensory Receptor Cells - immunology | Neuralgia - pathology | Microglia - immunology | Antineoplastic Agents - adverse effects | Spinal Cord - pathology | Neuralgia - chemically induced | Neurofilament Proteins - immunology | Spleen - pathology | Ganglia, Spinal - immunology | Sensory Receptor Cells - pathology | Microglia - drug effects | Mice, Inbred C57BL | Paclitaxel - adverse effects | Chemokine CCL2 - genetics | Animals | Sensory Receptor Cells - drug effects | CD8-Positive T-Lymphocytes - drug effects | Organoplatinum Compounds - adverse effects | Usage | Chemotherapy | Care and treatment | Oxalic acid | Polyneuropathies | Research | Diagnosis | T cells | Cancer | Spinal cord | Neurosciences | CD8 antigen | Carbon tetrachloride | Interleukin | Central nervous system | Transgenic | Nervous system | Diabetic neuropathy | Lymphocytes T | Cerebrospinal fluid | Peripheral neuropathy | Macrophages | Lymph nodes | Proteins | Neurotoxicity | Interleukin 4 | Pain | Dorsal root ganglia | Lymphocytes | Rodents | Sensory neurons | Tumor necrosis factor-TNF | Horns | Dorsal horn | Peripheral nervous system | Pain sensitivity | Spleen | Pain perception | Immune response | Cytokines | Granulocyte-macrophage colony-stimulating factor | Hypersensitivity | CCL3 protein | Interleukin 12 | Inflammation | CCL4 protein | Microglia | CD4 antigen | Studies | White blood cells | TNF inhibitors | Infiltration | Chemokines | Monocyte chemoattractant protein 1 | Index Medicus
Journal Article
PloS one, ISSN 1932-6203, 06/2014, Volume 9, Issue 6, pp. e100701 - e100701
Chemotherapy-induced peripheral neuropathy (CIPN) characterized by loss of sensory sensitivity and pain in hands and feet is the major dose-limiting toxicity of many chemotherapeutics... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Hyperalgesia - chemically induced | Hypoglycemic Agents - therapeutic use | Nerve Fibers - pathology | Neuralgia - complications | Peripheral Nervous System Diseases - chemically induced | Metformin - therapeutic use | Hyperalgesia - complications | Metformin - pharmacology | Mice, Inbred C57BL | Paclitaxel - adverse effects | Nerve Fibers - drug effects | Protective Agents - therapeutic use | Neuralgia - drug therapy | Hypoglycemic Agents - pharmacology | Animals | Hyperalgesia - drug therapy | Protective Agents - pharmacology | Cisplatin - adverse effects | Neuralgia - chemically induced | Peripheral Nervous System Diseases - complications | Peripheral Nervous System Diseases - drug therapy | Disease Models, Animal | Drugs | Prescribing | Chemotherapy | Analysis | Metformin | Diabetes | Drug therapy | Drug approval | Cisplatin | Diabetes therapy | Cancer | Neuroprotection | Neurosciences | Toxicity | Neurobiology | Neuropathy | Kinases | Peripheral neuropathy | Cancer therapies | Fibers | Pain | Rodents | Paclitaxel | Drug dosages | Tactile | Pain sensitivity | Nerve endings | Pain perception | Diabetes mellitus | Breast cancer | Metabolism | Apolipoproteins | Latency | Studies | Sensitivity | Hypotheses | Adhesives | Brain research | Mechanical stimuli | Laboratory animals | Index Medicus
Journal Article
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 11/2013, Volume 8, Issue 11, pp. e80915 - e80915
.... Therefore, identification of drugs that may effectively counteract paclitaxel-induced neuropathic symptoms is crucial... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Hyperalgesia - chemically induced | Peripheral Nervous System Diseases - chemically induced | Androstane-3,17-diol - pharmacology | Male | Peripheral Nervous System Diseases - physiopathology | Pain - chemically induced | Peripheral Nerves - drug effects | Neuroprotective Agents - pharmacology | Neuralgia - prevention & control | Peripheral Nervous System Diseases - prevention & control | Neuralgia - chemically induced | Neural Conduction - drug effects | Neuralgia - physiopathology | Action Potentials - drug effects | Antineoplastic Agents, Phytogenic - adverse effects | Nerve Fibers - pathology | Pain - prevention & control | Androstane-3,17-diol - analogs & derivatives | Hyperalgesia - prevention & control | Paclitaxel - adverse effects | Rats | Nerve Fibers - drug effects | Peripheral Nerves - pathology | Rats, Sprague-Dawley | Hyperalgesia - physiopathology | Animals | Pain - physiopathology | Pain Measurement | Drugs | Neuroprotection | Spinal cord | Neuropathology | Action potential | Nervous system | Kinases | Peripheral neuropathy | Cancer therapies | Experiments | Nerve conduction | Pain | Analgesics | Sheaths | Metabolites | Rodents | Paclitaxel | Public health | Phosphodiesterase | Pain perception | Myelin | Maintenance | Gene expression | Burning | Studies | Axons | Side effects | Chemotherapy | Laboratory animals | Dietary fiber | Cancer | Index Medicus | Conduction | Reversing
Journal Article
The Journal of neuroscience, ISSN 1529-2401, 01/2018, Volume 38, Issue 5, pp. 1124 - 1136
Journal Article